TY - JOUR
T1 - Clinical and Molecular Analysis in 2 Families With Novel Compound Heterozygous SBP2 (SECISBP2) Mutations
AU - Fu, Jiao
AU - Korwutthikulrangsri, Manassawee
AU - Gönç, E. Nazli
AU - Sillers, Laura
AU - Liao, Xiao Hui
AU - Alikaşifoǧlu, Ayfer
AU - Kandemir, Nurgün
AU - Menucci, Maria Belen
AU - Burman, Kenneth D.
AU - Weiss, Roy E.
AU - Dumitrescu, Alexandra M.
N1 - Funding Information:
Financial Support: This work was supported in part by grants
Funding Information:
DK110322 to A.M.D. from the National Institutes of Health, The Seymour J. Abrams and Rabbi Morris Esformes funds for Thyroid Research to R.E.W., and an Award from China Scholarship Council to J.F.
PY - 2020/1/8
Y1 - 2020/1/8
N2 - Context: Selenocysteine insertion sequence binding protein 2 (SECISBP2, SBP2) is an essential factor for selenoprotein synthesis. Individuals with SBP2 defects have characteristic thyroid function test (TFT) abnormalities resulting from deficiencies in the selenoenzymes deiodinases. Eight families with recessive SBP2 gene mutations have been reported to date. We report 2 families with inherited defect in thyroid hormone metabolism caused by 4 novel compound heterozygous mutations in the SBP2 gene. Case Descriptions: Probands 1 and 2 presented with growth and developmental delay. Both had characteristic TFT with high T4, low T3, high reverse T3, and normal or slightly elevated TSH. The coding region of the SBP2 gene was sequenced and analysis of in vitro translated wild-type and mutant SBP2 proteins was performed. Sequencing of the SBP2 gene identified novel compound heterozygous mutations resulting in mutant SBP2 proteins E679D and R197∗ in proband 1, and K682Tfs∗2 and Q782∗ in proband 2. In vitro translation of the missense E679D demonstrated all four isoforms, whereas R197∗ had only 2 shorter isoforms translated from downstream ATGs, and Q782∗, K682Tfs∗2 expressed isoforms with truncated C-terminus. Reduction in serum glutathione peroxidase enzymatic activity was also demonstrated in both probands. Conclusions: We report 2 additional families with mutations in the SBP2 gene, a rare inherited condition manifesting global selenoprotein deficiencies. Report of additional families with SBP2 deficiency and their evaluation over time is needed to determine the full spectrum of clinical manifestations in SBP2 deficiency and increase our understanding of the role played by SBP2 and selenoproteins in health and disease.
AB - Context: Selenocysteine insertion sequence binding protein 2 (SECISBP2, SBP2) is an essential factor for selenoprotein synthesis. Individuals with SBP2 defects have characteristic thyroid function test (TFT) abnormalities resulting from deficiencies in the selenoenzymes deiodinases. Eight families with recessive SBP2 gene mutations have been reported to date. We report 2 families with inherited defect in thyroid hormone metabolism caused by 4 novel compound heterozygous mutations in the SBP2 gene. Case Descriptions: Probands 1 and 2 presented with growth and developmental delay. Both had characteristic TFT with high T4, low T3, high reverse T3, and normal or slightly elevated TSH. The coding region of the SBP2 gene was sequenced and analysis of in vitro translated wild-type and mutant SBP2 proteins was performed. Sequencing of the SBP2 gene identified novel compound heterozygous mutations resulting in mutant SBP2 proteins E679D and R197∗ in proband 1, and K682Tfs∗2 and Q782∗ in proband 2. In vitro translation of the missense E679D demonstrated all four isoforms, whereas R197∗ had only 2 shorter isoforms translated from downstream ATGs, and Q782∗, K682Tfs∗2 expressed isoforms with truncated C-terminus. Reduction in serum glutathione peroxidase enzymatic activity was also demonstrated in both probands. Conclusions: We report 2 additional families with mutations in the SBP2 gene, a rare inherited condition manifesting global selenoprotein deficiencies. Report of additional families with SBP2 deficiency and their evaluation over time is needed to determine the full spectrum of clinical manifestations in SBP2 deficiency and increase our understanding of the role played by SBP2 and selenoproteins in health and disease.
KW - SBP2
KW - SECISBP2
KW - deiodinase
KW - selenoprotein
KW - thyroid hormone metabolism defect
UR - http://www.scopus.com/inward/record.url?scp=85079736922&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85079736922&partnerID=8YFLogxK
U2 - 10.1210/clinem/dgz169
DO - 10.1210/clinem/dgz169
M3 - Article
C2 - 32084277
AN - SCOPUS:85079736922
VL - 105
JO - Journal of Clinical Endocrinology and Metabolism
JF - Journal of Clinical Endocrinology and Metabolism
SN - 0021-972X
IS - 3
M1 - dgz169
ER -